1,477
Views
4
CrossRef citations to date
0
Altmetric
Addendum

Strain-level analysis of gut-resident pro-inflammatory viridans group Streptococci suppressed by long-term cotrimoxazole prophylaxis among HIV-positive children in Zimbabwe

ORCID Icon, ORCID Icon, , , , & show all
Pages 1104-1115 | Received 30 Sep 2019, Accepted 07 Jan 2020, Published online: 05 Feb 2020

References

  • Forrest RD. Early history of wound treatment. J R Soc Med. 1982;75:198–205.
  • Wainwright M. Moulds in ancient and more recent medicine. Top Catal. 1989;3:21–23.
  • Nicolaou KC, Rigol S. A brief history of antibiotics and select advances in their synthesis. J Antibiot (Tokyo). 2018;71:153–184.
  • Spížek J, Sigler K, Řezanka T, Demain A. Biogenesis of antibiotics—viewing its history and glimpses of the future. Folia Microbiol (Praha). 2016;61(4):347–358. doi:10.1007/s12223-016-0462-y.
  • Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42(Suppl 2):S82–9. doi:10.1086/499406.
  • Ferrer M, Méndez-García C, Rojo D, Barbas C, Moya A. Antibiotic use and microbiome function. Biochem Pharmacol. 2017;134:114–126. doi:10.1016/j.bcp.2016.09.007.
  • Bucci V, Bradde S, Biroli G, Xavier JB. Social interaction, noise and antibiotic-mediated switches in the intestinal microbiota. PLoS Comput Biol. 2012;8(4):e1002497. doi:10.1371/journal.pcbi.1002497.
  • Gerber GK, Onderdonk AB, Bry L. Inferring dynamic signatures of microbes in complex host ecosystems. PLoS Comput Biol. 2012;8(8):e1002624. doi:10.1371/journal.pcbi.1002624.
  • Shaw LP, Bassam H, Barnes CP, Walker AS, Klein N, Balloux F. Modelling microbiome recovery after antibiotics using a stability landscape framework. ISME J. 2019;13(7):1845–1856. doi:10.1038/s41396-019-0392-1.
  • Newton DF, Macfarlane S, Macfarlane GT. Effects of antibiotics on bacterial species composition and metabolic activities in chemostats containing defined populations of human gut microorganisms. Antimicrob Agents Chemother. 2013;57(5):2016–2025. doi:10.1128/AAC.00079-13.
  • Ponziani FR, Scaldaferri F, Petito V, Paroni Sterbini F, Pecere S, Lopetuso LR, Palladini A, Gerardi V, Masucci L, Pompili M, et al. The role of antibiotics in gut microbiota modulation: the eubiotic effects of rifaximin. Dig Dis. 2016;34(3):269–278. doi:10.1159/000443361.
  • Scholz M, Ward DV, Pasolli E, Tolio T, Zolfo M, Asnicar F, Truong DT, Tett A, Morrow AL, Segata N, et al. Strain-level microbial epidemiology and population genomics from shotgun metagenomics. Nat Methods. 2016;13(5):435–438. doi:10.1038/nmeth.3802.
  • Cani PD, Van Hul M. Novel opportunities for next-generation probiotics targeting metabolic syndrome. Curr Opin Biotechnol. 2015;32:21–27. doi:10.1016/j.copbio.2014.10.006.
  • Wick EC, Sears CL. Bacteroides spp. and diarrhea. Curr Opin Infect Dis. 2010;23(5):470–474. doi:10.1097/QCO.0b013e32833da1eb.
  • Sitkiewicz I. How to become a killer, or is it all accidental? Virulence strategies in oral streptococci. Mol Oral Microbiol. 2018;33(1):1–12. doi:10.1111/omi.2018.33.issue-1.
  • Keenan JD, Arzika AM, Maliki R, Boubacar N, Adamou SE, Ali MM, Cook C, Lebas E, Lin Y, Ray KJ, et al. Longer-term assessment of azithromycin for reducing childhood mortality in Africa. N Engl J Med. 2019;380(23):2207–2214. doi:10.1056/NEJMoa1817213.
  • Bwakura-Dangarembizi M, Kendall L, Bakeera-Kitaka S, Nahirya-Ntege P, Keishanyu R, Nathoo K, Spyer MJ, Kekitiinwa A, Lutaakome J, Mhute T, et al. A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa. N Engl J Med. 2014;370(1):41–53. doi:10.1056/NEJMoa1214901.
  • Penakalapati G, Swarthout J, Delahoy MJ, McAliley L, Wodnik B, Levy K, Freeman MC. Exposure to animal feces and human health: a systematic review and proposed research priorities. Environ Sci Technol. 2017;51(20):11537–11552. doi:10.1021/acs.est.7b02811.
  • Platts-Mills JA, Liu J, Rogawski ET, Kabir F, Lertsethtakarn P, Siguas M, Khan SS, Praharaj I, Murei A, Nshama R. Use of quantitative molecular diagnostic methods to assess the aetiology, burden, and clinical characteristics of diarrhoea in children in low-resource settings: a reanalysis of the MAL-ED cohort study. Lancet Global Health. 2018;6(12):e1309–18. doi:10.1016/S2214-109X(18)30349-8.
  • Liu J, Platts-Mills JA, Juma J, Kabir F, Nkeze J, Okoi C, Operario DJ, Uddin J, Ahmed S, Alonso PL, et al. Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study. Lancet. 2016;388(10051):1291–1301. doi:10.1016/S0140-6736(16)31529-X.
  • Cotton MF, Wasserman E, Smit J, Whitelaw A, Zar HJ. High incidence of antimicrobial resistant organisms including extended spectrum beta-lactamase producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus in nasopharyngeal and blood isolates of HIV-infected children from Cape Town, South. BMC Infect Dis. 2008;8:40. doi:10.1186/1471-2334-8-40.
  • Musiime V, Cook A, Bakeera-Kitaka S, Vhembo T, Lutakome J, Keishanyu R, Prendergast AJ, Lubwama S, Robertson V, Hughes P, et al. Bacteremia, causative agents and antimicrobial susceptibility among HIV-1-infected children on antiretroviral therapy in Uganda and Zimbabwe. Pediatr Infect Dis J. 2013;32(8):856–862. doi:10.1097/INF.0b013e31828c3991.
  • Tunnicliff R. The action of prontosil-soluble and sulfanilamide on the phagocytic activity of leukocytes and on the dissociation of Streptococci. J Infect Dis. 2019;64(1):59–65. doi:10.1093/infdis/64.1.59.
  • Altenburg J, De Graaff CS, Van Der Werf TS, Boersma WG. Immunomodulatory effects of macrolide antibiotics - Part 1: biological mechanisms. Respiration. 2010;81(1):67–74. doi:10.1159/000320319.
  • Garrido-Mesa N, Zarzuelo A, Gálvez J. What is behind the non-antibiotic properties of minocycline? Pharmacol Res. 2013;67(1):18–30. doi:10.1016/j.phrs.2012.10.006.
  • Ghilchik MW, Morris AS, Reeves DS. Immunosuppressive powers of the antibacterial agent trimethoprim. Nature. 1970;227:393–394. doi:10.1038/227393a0.
  • WHO. Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents and children: recommendations for a public health approach - December 2014 supplement to the 2013 consolidated A. Geneva (Switzerland): WHO Press; 2014.
  • Church JA, Fitzgerald F, Walker AS, Gibb DM, Prendergast AJ. The expanding role of co-trimoxazole in developing countries. Lancet Infect Dis. 2015;15:327–339. doi:10.1016/S1473-3099(14)71011-4.
  • Bourke CD, Gough EK, Pimundu G, Shonhai A, Berejena C, Terry L, Baumard L, Choudhry N, Karmali Y, Bwakura-Dangarembizi M, et al. Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation. Sci Transl Med. 2019;11(486):1–14. doi:10.1126/scitranslmed.aav0537.
  • Heuston S, Begley M, Gahan CGM, Hill C. Isoprenoid biosynthesis in bacterial pathogens. Microbiology (UK). 2012;158:1389–1401.
  • Dunzendorfer S, Rothbucher D, Schratzberger P, Reinisch N, Kähler CM, Wiedermann CJ. Mevalonate-dependent inhibition of transendothelial migration and chemotaxis of human peripheral blood neutrophils by pravastatin. Circ Res. 1997;81:963–969. doi:10.1161/01.RES.81.6.963.
  • Kaneider NC, Reinisch CM, Dunzendorfer S, Meierhofer C, Djanani A, Wiedermann CJ. Induction of apoptosis and inhibition of migration of inflammatory and vascular wall cells by cerivastatin. Atherosclerosis. 2001;158(1):23–33. doi:10.1016/S0021-9150(00)00764-4.
  • Zhang FL. Protein prenylation: molecular mechanisms and functional consequences. Annu Rev Biochem. 1996;65(1):241–269. doi:10.1146/annurev.bi.65.070196.001325.
  • Niggli V. Rho-kinase in human neutrophils: A role in signalling for myosin light chain phosphorylation and cell migration. FEBS Lett. 1999;445(1):69–72. doi:10.1016/S0014-5793(99)00098-8.
  • Maher BM, Dhonnchu TN, Burke JP, Soo A, Wood AE, Watson RWG. Statins alter neutrophil migration by modulating cellular Rho activity–a potential mechanism for statins-mediated pleotropic effects? J Leukoc Biol. 2008;85(1):186–193. doi:10.1189/jlb.0608382.
  • Elmore MA, daniels RH, Hill ME, Finnen MJ. Inhibition of neutrophil priming by inhibitors of farnesyl transferase. Biochem Soc Trans. 1997;25:253S. doi:10.1042/bst025253s.
  • Terkeltaub R, Solan J, Barry M, Santoro D, Bokoch GM. Role of the mevalonate pathway of isoprenoid synthesis in IL-8 generation by activated monocytic cells. J Leukoc Biol. 1994;55(6):749–755. doi:10.1002/jlb.55.6.749.
  • Van Den Bogert B, Meijerink M, Zoetendal EG, Wells JM, Kleerebezem M. Immunomodulatory properties of streptococcus and veillonella isolates from the human small intestine microbiota. PLoS One. 2014;9(12):1–20. doi:10.1371/journal.pone.0114277.
  • Bokoch GM, Prossnitz V. Isoprenoid metabolism is required for stimulation of the respiratory burst oxidase of HL-60 cells. J Clin Invest. 1992;89(2):402–408. doi:10.1172/JCI115599.
  • Allen RC, Stephens JT. Myeloperoxidase selectively binds and selectively kills microbes. Infect Immun. 2011;79(1):474–485. doi:10.1128/IAI.00910-09.
  • Davies M. Myeloperoxidase?derived oxidation: mechanisms review the society for free radical research Japan journal of clinical biochemistry and nutrition of biological damage and its prevention. J Clin Biochem Nutr. 2011 10.3164/jcb. 1880 50860912-0009 R oto, Japan Kyjcbn11-006FR11-006FR JJCBN;48(1):8–19. doi:10.3164/jcbn.11-006FR.
  • Brenchley JM, Douek DC. HIV infection and the gastrointestinal immune system. Mucosal Immunol. 2008;1(1):23–30. doi:10.1038/mi.2007.1.
  • Doern CD, Burnham CAD. It’s not easy being green: the viridans group streptococci, with a focus on pediatric clinical manifestations. J Clin Microbiol. 2010;48(11):3829–3835. doi:10.1128/JCM.01563-10.
  • Van Den Bogert B, Boekhorst J, Herrmann R, Smid EJ, Zoetendal EG, Kleerebezem M. Comparative genomics analysis of Streptococcus isolates from the human small intestine reveals their adaptation to a highly dynamic ecosystem. PLoS One. 2013;8(12):e83418. doi:10.1371/journal.pone.0083418.
  • Vonaesch P, Morien E, Andrianonimiadana L, Sanke H, Mbecko JR, Huus KE, Naharimanananirina T, Gondje BP, Nigatoloum SN, Vondo SS, et al. Stunted childhood growth is associated with decompartmentalization of the gastrointestinal tract and overgrowth of oropharyngeal taxa. Proc Natl Acad Sci U S A. 2018;115(36):E8489–98. doi:10.1073/pnas.1806573115.
  • Tefsen B, Ram AFJ, Van Die I, Routier FH. Galactofuranose in eukaryotes: aspects of biosynthesis and functional impact. Glycobiology. 2012;22(4):456–469. doi:10.1093/glycob/cwr144.
  • Biswas I, Drake L, Erkina D, Biswas S. Involvement of sensor kinases in the stress tolerance response of Streptococcus mutans. J Bacteriol. 2008;190(1):68–77. doi:10.1128/JB.00990-07.
  • Feltcher ME, Braunstein M. Emerging themes in SecA2-mediated protein export. Nat Rev Microbiol. 2012;10(11):779–789. doi:10.1038/nrmicro2874.
  • Prindle A, Liu J, Asally M, Ly S, Garcia-Ojalvo J, Süel GM. Ion channels enable electrical communication in bacterial communities. Nature. 2015;527(7576):59–63. doi:10.1038/nature15709.
  • Pasolli E, Asnicar F, Manara S, Zolfo M, Karcher N, Armanini F, Beghini F, Manghi P, Tett A, Ghensi P, et al. Extensive unexplored human microbiome diversity revealed by over 150,000 genomes from metagenomes spanning age, geography, and lifestyle. Cell. 2019;176(3):649–662. doi:10.1016/j.cell.2019.01.001.
  • Oldenburger IB, Wolters VM, Kardol-Hoefnagel T, Houwen RHJ, Otten HG. Serum intestinal fatty acid–binding protein in the noninvasive diagnosis of celiac disease. Apmis. 2018;126(3):186–190. doi:10.1111/apm.2018.126.issue-3.
  • Kyosiimire-Lugemwa J, Anywaine Z, Abaasa A, Levin J, Gombe B, Musinguzi K, Kaleebu P, Grosskurth H, Munderi P, Pala P, et al. Effect of Stopping Cotrimoxazole preventive therapy on microbial translocation and inflammatory markers among human immunodeficiency virus-infected ugandan adults on antiretroviral therapy: the COSTOP trial immunology substudy. J Infect Dis. 2019. doi:10.1093/infdis/jiz494.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.